Medication (generic)
Atorvastatin
Starting dose
10-20 mg once daily
Typical titration / target
40-80 mg daily for high-intensity
Monitoring / notes
Check baseline ALT; repeat if symptomatic.
Prescribing
Statin initiation
Common statin starting doses with intensity targets and monitoring reminders.
Last reviewed 2026-01-05|cardio | lipids | medication
Editorial feedback
Suggest an update
Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.
Jump to
Dosing quick reference
Medication (generic)
Rosuvastatin
Starting dose
5-10 mg once daily
Typical titration / target
20-40 mg daily for high-intensity
Monitoring / notes
Use lower start in Asian ancestry or renal impairment.
Medication (generic)
Simvastatin
Starting dose
10-20 mg once daily
Typical titration / target
Max 40 mg daily
Monitoring / notes
Avoid strong CYP3A4 inhibitors and grapefruit.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Atorvastatin | 10-20 mg once daily | 40-80 mg daily for high-intensity | Check baseline ALT; repeat if symptomatic. |
| Rosuvastatin | 5-10 mg once daily | 20-40 mg daily for high-intensity | Use lower start in Asian ancestry or renal impairment. |
| Simvastatin | 10-20 mg once daily | Max 40 mg daily | Avoid strong CYP3A4 inhibitors and grapefruit. |
Contraindications
- Avoid in active liver disease or unexplained persistent severe transaminase elevation.
- Avoid with contraindicated interacting medications that markedly increase statin toxicity risk.
- Avoid initiation during pregnancy.
Renal and hepatic considerations
- Check baseline ALT and review hepatic history before initiation.
- Use conservative starts when renal impairment is present for dose-sensitive agents.
- Review interaction burden (including CYP-mediated interactions) before up-titration.
Pregnancy and lactation cautions
- Statins are generally not used during pregnancy; discontinue and reassess plan if pregnancy is planned or confirmed.
- Provide preconception counseling before long-term therapy in reproductive-age patients.
- Avoid routine statin use during lactation unless specialist-led risk-benefit justification exists.
Monitoring checkpoints
- Recheck lipids 6-12 weeks after initiation or titration.
- Review muscle symptoms and consider CK if severe.
- Reinforce lifestyle interventions alongside medication.
Stop or escalate criteria
- Stop and escalate for suspected rhabdomyolysis, severe myopathy, or significant hepatic injury signals.
- Escalate when LDL targets are not met despite adherence and tolerated dose optimization.
- Escalate early when adverse effects limit evidence-based intensity in high-risk patients.